SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-012650
Filing Date
2019-05-08
Accepted
2019-05-08 17:00:23
Documents
1
Period of Report
2019-05-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4344
  Complete submission text file 0000899243-19-012650.txt   5712
Mailing Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Issuer) CIK: 0001563880 (see all company filings)

IRS No.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102
Business Address
Nadav Eran (Reporting) CIK: 0001587852 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38886 | Film No.: 19807466